SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology | BioSpace Source Cluster: BioSpace Source Node: 3092730Time Stamp: Jan 31, 2024
Bright Green Corporation to acquire platform technologies from C2 Wellness Source Cluster: MGRetailer Source Node: 3085085Time Stamp: Jan 25, 2024
ADM Endeavors Provides Corporate Update Source Cluster: JCN Newswire Source Node: 3084429Time Stamp: Jan 25, 2024
Core Scientific, Inc. Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Competitive Position Source Cluster: Fintech News Source Node: 3081824Time Stamp: Jan 23, 2024
Core Scientific, Inc. Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Competitive Position Source Cluster: TheNewsCrypto Source Node: 3081271Time Stamp: Jan 23, 2024
Teledyne to Hold Investor Meetings Source Cluster: Fintech News Source Node: 3070542Time Stamp: Jan 18, 2024
Loop Industries Announces MOU For US$66 Million of Non-Dilutive Financing from Reed Management, as Part of a Joint Venture for European Infinite Loop(TM) Technology Roll-Out Source Cluster: ACN Newswire Source Node: 3069838Time Stamp: Jan 18, 2024
Core Scientific, Inc. Plan of Reorganization Confirmed by Bankruptcy Court Source Cluster: TheNewsCrypto Source Node: 3065959Time Stamp: Jan 16, 2024
“The Time is Now” to Maximize Human Healthspan: A Discussion with Peter Diamandis, Hans Keirstead, Daniel Kraft and Jane Metcalfe Source Cluster: Fintech News Source Node: 3057468Time Stamp: Jan 11, 2024
SeaStar Medical Appoints David A. Green as Chief Financial Officer | BioSpace Source Cluster: BioSpace Source Node: 3059839Time Stamp: Jan 10, 2024
JetBlue Announces CEO Succession Source Cluster: Fintech News Source Node: 3052303Time Stamp: Jan 8, 2024
Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results | BioSpace Source Cluster: BioSpace Source Node: 3053350Time Stamp: Jan 8, 2024
SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications | BioSpace Source Cluster: BioSpace Source Node: 3053353Time Stamp: Jan 8, 2024
U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum Source Cluster: Fintech News Source Node: 3049508Time Stamp: Jan 5, 2024
Core Scientific, Inc. Announces Full Pay Down of Debtor-in-Possession Financing Source Cluster: Fintech News Source Node: 3047259Time Stamp: Jan 4, 2024
Core Scientific, Inc. Announces Full Pay Down of Debtor-in-Possession Financing Source Cluster: TheNewsCrypto Source Node: 3046521Time Stamp: Jan 4, 2024
Avanos Medical, Inc. Reports Preliminary Fourth Quarter and Full-Year 2023 Financial Results; Revises Preliminary 2024 Revenue Outlook | BioSpace Source Cluster: BioSpace Source Node: 3047941Time Stamp: Jan 3, 2024
Faraday Future Delivers an FF 91 2.0 to its Newest User, Jim Gao, Vice President of FF’s Intelligent Internet Application Service Platform, Marking Ten Deliveries by the Company in 2023 Source Cluster: Fintech News Source Node: 3044640Time Stamp: Jan 2, 2024
SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury | BioSpace Source Cluster: BioSpace Source Node: 3039348Time Stamp: Dec 27, 2023